Skip to main content

CorMedix Inc. Common Stock (CRMD)

About The Company

CRMD Stock Market Logo

Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis,total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical needs.

IPO Year Sector Industry
N/A Health Care Biotechnology: Pharmaceutical Preparations

CorMedix Inc. (CRMD) Latest News

Company Contact & Address (CRMD)

Corporate Headquarters Phone Website
New Jersey,
United States
+1 908 517-9500 Official CRMD Website

CRMD Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ CRMD

Jobs & Employment at CorMedix Inc.

LinkedIn Company Page
Official Career & Employment Page Jobs & Careers at CorMedix Inc. (CRMD)

Related & Similar Stock Symbols

NBO Stock Market Price & News


Neuberger Berman New York Municipal Fund Inc. …

GPACU Stock Market Price & News


Global Partner Acquisition Corp II Unit

PKI Stock Market Price & News


PerkinElmer Inc. Common Stock